Anti-thrombotic technologies for medical devices

Area of Science:

• Biomaterials Science
• Medical Device Engineering
• Hematology

Background:

• Thrombosis linked to medical devices significantly elevates patient morbidity, mortality, and healthcare expenses.
• Developing a safe, biocompatible interface between medical devices and blood is crucial for patient outcomes.
• Understanding the biological mechanisms of device-associated thrombosis is key to mitigating this complication.

Purpose of the Study:

• To elucidate the biological phenomena driving thrombosis associated with medical devices.
• To review current and emerging technologies aimed at preventing device-related thrombosis.
• To assess the potential of novel biomaterials and surface modifications in combating thrombosis.

Main Methods:

• Literature review of biological mechanisms of device-associated thrombosis.
• Survey of existing and developing technologies for thrombosis reduction.
• Analysis of biomaterial properties, including topography and anti-thrombogenic surface modifications.

Main Results:

• Biomaterials with tailored topographical features show potential for reducing thrombosis.
• Surface incorporation of anti-thrombogenic substances offers a promising strategy.
• Extensive technical solutions are documented in the literature for mitigating device-associated thrombosis.

Conclusions:

• Surface modifications and advanced biomaterials are viable strategies to reduce device-associated thrombosis.
• Further clinical studies are essential to confirm the long-term efficacy and benefits of these technologies.
• Bridging the gap between technical innovation and clinical validation is critical for improving patient care.